Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.62NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.80 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.80 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.43.8 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.43.8 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.128 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.128 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AZ.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AZ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.270NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.270NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.227NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.227NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
U.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
U.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.436NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.436NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.558NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.558NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.518NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.518NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.368NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.368NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.404NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.404NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.24NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.236NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.236NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.153NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.153NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.302NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.302NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.194NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.194NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.51NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.308NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.308NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used